Endotracheal Tube Market, By Product Type (Cuffed, Uncuffed, Armored/Reinforced, and Others), By Route of Administration (Orotracheal and Nasotracheal), By End User (Hospitals, Ambulatory Surgical Centers, and Others), By Geography (North America, Latin America, Asia Pacific, Europe, Middle East, and Africa)

Published In : Nov 2024

Code : CMI2564

Pages :183

Formats :

Excel and PDF

Industry : Medical Devices

Key Developments

In November 2023, The University of Nottingham, a public university in Nottingham, England, announced that they had received a funding from the Medical Research Council, the co-coordinating and funding medical research group in the U.K. to undertake human trials for the world’s first optical fiber sensor-equipped endotracheal tube (iTraXS). iTraXS has been developed in collaboration with P3 Medical Ltd, a manufacturer of endotracheal tubes.
In August 2021, researchers at the Children's Hospital of Philadelphia (CHOP) announced the development of a novel coating for endotracheal tubes that releases antimicrobial peptides to fight bacterial infections. This innovation aims to reduce upper-airway inflammation during intubation, potentially preventing chronic conditions such as subglottic stenosis.
In May 2021, Medtronic, a medical technology company, announced the U.S. commercial launch of the SonarMed airway monitoring system. This innovative system employs acoustic technology to detect endotracheal tube (ETT) obstructions and verify their position in real-time, providing clinicians with crucial information to make informed, life-saving decisions for their patients.